Literature DB >> 19829367

Neuroscience: Alzheimer's disease.

Lennart Mucke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19829367     DOI: 10.1038/461895a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

Review 1.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

Review 2.  100 years and counting: prospects for defeating Alzheimer's disease.

Authors:  Erik D Roberson; Lennart Mucke
Journal:  Science       Date:  2006-11-03       Impact factor: 47.728

  2 in total
  117 in total

Review 1.  Nanopore analysis: An emerging technique for studying the folding and misfolding of proteins.

Authors:  Claudia Madampage; Omid Tavassoly; Chris Christensen; Meena Kumari; Jeremy S Lee
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

Review 2.  Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Authors:  Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases.

Authors:  Patrick Provost
Journal:  Aging (Albany NY)       Date:  2010-03-31       Impact factor: 5.682

Review 4.  MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.

Authors:  Patrick Provost
Journal:  Brain Res       Date:  2010-03-27       Impact factor: 3.252

Review 5.  Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

6.  [Effect of intrahippocampal injection of anti-cellular prion protein monoclonal antibody on cognitive deficits in APPswe/PSEN1dE9 transgenic mice].

Authors:  Hai-Ying Zhang; Yi-Heng Liu; Yuan Fu; Peng-Cheng Chen; Rui Lu; Jian-Xing Li; Ming-Hui Chen; Hao-Chi Yang; Yu-Sheng Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-04-20

7.  Angiotensin-converting enzyme gene polymorphisms and risk for sporadic Alzheimer's disease: a meta-analysis.

Authors:  Xue-Bin Wang; Ning-Hua Cui; Jia-Jia Gao; Xue-Ping Qiu; Na Yang; Fang Zheng
Journal:  J Neural Transm (Vienna)       Date:  2014-05-23       Impact factor: 3.575

8.  Distinct transcriptome expression of the temporal cortex of the primate Microcebus murinus during brain aging versus Alzheimer's disease-like pathology.

Authors:  Ronza Abdel Rassoul; Sabine Alves; Véronique Pantesco; John De Vos; Bernard Michel; Martine Perret; Nadine Mestre-Francés; Jean-Michel Verdier; Gina Devau
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

9.  The chick as a model for the study of the cellular mechanisms and potential therapies for Alzheimer's disease.

Authors:  Radmila Mileusnic; Steven Rose
Journal:  Int J Alzheimers Dis       Date:  2010-07-18

10.  In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy.

Authors:  Pradeep Kumar; Viness Pillay; Yahya E Choonara; Girish Modi; Dinesh Naidoo; Lisa C du Toit
Journal:  Int J Mol Sci       Date:  2011-01-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.